46 results on '"Bruno, Teresa"'
Search Results
2. Uncertainty in magnetic resonance imaging-based prostate postimplant dosimetry: Results of a 10-person human observer study, and comparisons with automatic postimplant dosimetry
3. The American Brachytherapy Society prostate brachytherapy LDR/HDR simulation workshops: Hands-on, step-by-step training in the process of quality assurance
4. Development, implementation, and outcomes of a simulation-based medical education (SBME) prostate brachytherapy workshop for radiation oncology residents
5. Quality comparison between three-dimensional T2-weighted SPACE and two-dimensional T2-weighted turbo spin echo magnetic resonance images for the brachytherapy planning evaluation of prostate and periprostatic anatomy
6. Clinical utility and value contribution of an MRI-positive line marker for image-guided brachytherapy in gynecologic malignancies
7. MRI-assisted radiosurgery: A quality assurance nomogram for palladium-103 and iodine-125 prostate brachytherapy
8. A relationship between environmental pollutants and enteric viruses in mussels(Mytilus galloprovincialis)
9. Parallel imaging compressed sensing for accelerated imaging and improved signal-to-noise ratio in MRI-based postimplant dosimetry of prostate brachytherapy
10. Permanent prostate brachytherapy postimplant magnetic resonance imaging dosimetry using positive contrast magnetic resonance imaging markers
11. Permanent prostate brachytherapy pubic arch evaluation with diagnostic magnetic resonance imaging
12. Sexual potency preservation and quality of life after prostate brachytherapy and low-dose tadalafil
13. MRI-based sector analysis enhances prostate palladium-103 brachytherapy quality assurance in a phase II prospective trial of men with intermediate-risk localized prostate cancer
14. Improving prostate brachytherapy quality assurance with MRI–CT fusion–based sector analysis in a phase II prospective trial of men with intermediate-risk prostate cancer
15. An MRI-based dose–response analysis of urinary sphincter dose and urinary morbidity after brachytherapy for prostate cancer in a phase II prospective trial
16. PPP05 Presentation Time: 11:06 AM: Proton Therapy with Brachytherapy Boost in Patients with Prostate Cancer: The MD Anderson Cancer Center Experience
17. Magnetic resonance imaging-based treatment planning for prostate brachytherapy
18. Screening colonoscopy before prostate cancer treatment can detect colorectal cancers in asymptomatic patients and reduce the rate of complications after brachytherapy
19. Preoperative treatment planning with intraoperative optimization can achieve consistent high-quality implants in prostate brachytherapy
20. Displacement of periurethral stranded seeds and its dosimetric consequences in prostate brachytherapy
21. Impact of urinary catheterization on dosimetry after prostate implant brachytherapy with palladium-103 or iodine-125
22. Urinary Side Effects and Complications After Permanent Prostate Brachytherapy: The MD Anderson Cancer Center Experience
23. Prostogram Predicted Brachytherapy Outcomes are Not Universally Accurate: An Analysis Based on the M. D. Anderson Cancer Center Experience With 125Iodine Brachytherapy
24. PSOR06 Presentation Time: 12:25 PM: Early Outcomes and Hormone-Free Survival Following Salvage MARS for MRI-Visible Post-Surgical Bed Recurrences and Focal Intraprostatic Recurrences Following External Beam and Following Brachytherapy
25. PO24 Presentation Time: 7:40 AM: Impact of Intra-Operative MRI-Guidance on Dose Escalation to the HR-CTV Using Advanced Gynecological Applicators
26. PP09 Presentation Time: 10:50 AM: Interobserver Variability of Prostate MRI-Assisted Radiosurgery Postimplant Dosimetry: Comparison with Automatic Postimplant Dosimetry
27. PP06 Presentation Time: 9:50 AM: Biochemical Failure-Free Survival Rates After Brachytherapy with I-125, Pd-103, or Cs-131 for Intermediate-Risk Prostate Cancer: Phase II Trial
28. PO37: Autosegmentation in the Clinic: Initial Experiences with LDR Prostate Cancer Patients from Two MRI-Based Practices
29. PRSOR03 Presentation Time: 12:10 PM: Interobserver Variability of Target and OAR Delineation in MRI-Based Prostate Brachytherapy across Two Anatomical Pulse Sequences
30. Longer Preoperative Membranous Urethral Length is Associated with GU Toxicity after Permanent Prostate Brachytherapy
31. An MRI-Based Nomogram for Palladium and Iodine Prostate Brachytherapy Quality Assurance
32. Multi-Tasking Neural Networks for Anatomy Segmentation in Prostate Brachytherapy MRI
33. Prospective Cohort of Permanent Seed Implantation Prostate Brachytherapy for Intermediate Risk Prostate Cancer: Analysis of Patient Satisfaction and Interference with Daily Activities between 125-iodine, 103-palladium and 131-cesium
34. Permanent Seed Implantation Prostate Brachytherapy for Intermediate Risk Prostate Cancer: Efficacy and Toxicity Outcomes from a Prospective Cohort of 300 Patients
35. Are We Ready to Replace Post-Implant CT Dosimetry? Permanent Prostate Brachytherapy Post-Implant MRI Dosimetry Using Positive Contrast MRI Markers
36. MRI Simulation for LDR Prostate Brachyhtherapy: Can We Replace Ultrasound with MRI for Treatment Planning? Comparison of Pre-Planning, Day 0 and Day 30 MR Dosimetry
37. Prospective Cohort of Permanent Seed Implantation Prostate Brachytherapy for Intermediate Risk Prostate Cancer: Patient Reported Outcomes and Comparison of Toxicity Profiles between 125-iodine, 131-cesium and 103-palladium
38. Initial Patient Experience With Positive-Contrast MRI Markers for Low-Dose-Rate Prostate Brachytherapy
39. Dose Reduction to Rectum and Bladder Using the Fletcher CT/MR Shielded Applicator for Cervical Cancer Brachytherapy
40. 131Cs Stranded-Seed Nomogram for a Prospective Phase II Intermediate-Risk Low-Dose-Rate Prostate Brachytherapy Clinical Trial
41. Prostate Brachytherapy Treatment Planning Using T2-Weighted Cube 3D Magnetic Resonance Imaging without an Endorectal Coil
42. Comparison of Two Commercial Treatment Planning Systems Variseed and Mim for Low-Dose-Rate Prostate Brachytherapy
43. Long-Term Outcomes, Quality of Life, and Patient-Reported Satisfaction Following Prostate Brachytherapy: The M.D. Anderson Cancer Center Experience
44. An MRI Dose Response Analysis for Urinary Morbidity Following Prostate Brachytherapy Monotherapy in a Phase II Prospective Trial
45. Sexual outcomes unaffected by penile bulb dose in prostate brachytherapy
46. PROSTATE BRACHYTHERAPY – THE M.D. ANDERSON CANCER CENTER EXPERIENCE
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.